The DOI matches its Crossref record; 75 of the 77 references it cites were found in a registry or an index.
NMDA Receptor Subunits Have Differential Roles in Mediating Excitotoxic Neuronal Death Both In Vitro and In Vivo
Open accessAbstract
Well-documented experimental evidence from both in vitro and in vivo models of stroke strongly supports the critical involvement of NMDA receptor-mediated excitotoxicity in neuronal damage after stroke. Despite this, the results of clinical trials testing NMDA receptor antagonists as neuroprotectants after stroke and brain trauma have been discouraging. Here, we report that in mature cortical cultures, activation of either synaptic or extrasynaptic NR2B-containing NMDA receptors results in excitotoxicity, increasing neuronal apoptosis. In contrast, activation of either synaptic or extrasynaptic NR2A-containing NMDA receptors promotes neuronal survival and exerts a neuroprotective action against both NMDA receptor-mediated and non-NMDA receptor-mediated neuronal damage. A similar opposing action of NR2B and NR2A in mediating cell death and cell survival was also observed in an in vivo rat model of focal ischemic stroke. Moreover, we found that blocking NR2B-mediated cell death was effective in reducing infarct volume only when the receptor antagonist was given before the onset of stroke and not 4.5 h after stroke. In great contrast, activation of NR2A-mediated cell survival signaling with administration of either glycine alone or in the presence of NR2B antagonist significantly attenuated ischemic brain damage even when delivered 4.5 h after stroke onset. Together, the present work provides a molecular basis for the dual roles of NMDA receptors in promoting neuronal survival and mediating neuronal damage and suggests that selective enhancement of NR2A-containing NMDA receptor activation with glycine may constitute a promising therapy for stroke.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The hypoxia-inducible transcription factor HIF-1α plays a primary role in the negative regulation of PGC-1α [84].”
From Protective Effects of PGC-1α Activators on Ischemic Stroke in a Rat Model of Photochemically Induced Thrombosis (2021) · cites this paper as [84]
Citations
Cites
Reversible middle cerebral artery occlusion without craniectomy in rats.
Longa, E. Z., Weinstein, P. R., Carlson, S., & Cummins, R. (1989) · Stroke · doi:10.1161/01.str.20.1.84 · Cited by 7,463
Monyer, H., Burnashev, N., Laurie, D. J., Sakmann, B., & Seeburg, P. H. (1994) · Neuron · doi:10.1016/0896-6273(94)90210-0 · Cited by 3,535
Benveniste, H., Drejer, J., Schousboe, A., & Diemer, N. H. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb05396.x · Cited by 2,863
Bederson, J. B., Pitts, L. H., Tsuji, M., Nishimura, M. C., Davis, R. L., & Bartkowski, H. (1986) · Stroke · doi:10.1161/01.str.17.3.472 · Cited by 2,681
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,676
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P., & Lipton, S. A. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7162 · Cited by 1,958
Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways
Hardingham, G. E., Fukunaga, Y., & Bading, H. (2002) · Nature Neuroscience · doi:10.1038/nn835 · Cited by 1,686
Functional Repression of cAMP Response Element in 6-Hydroxydopamine-treated Neuronal Cells
Chalovich, E. M., Zhu, J.-H., Caltagarone, J., Bowser, R., & Chu, C. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602632200 · Cited by 1,385
Cited by
Sorted by citations
Items 501–600 of 777
Activity‐dependent regulation of NMDA receptors in substantia nigra dopaminergic neurones
Wild, A. R., Jones, S., & Gibb, A. J. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.267310 · Cited by 13
Huang, B., Xie, Q., Lu, X., Qian, T., Li, S., Zhu, R., Wan, Y., Chen, G., Chen, Z., Xu, X., et al. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000445556 · Cited by 14
Armstead, W. M., Riley, J., Yarovoi, S. V., Higazi, A. A., & Cines, D. B. (2016) · Stroke · doi:10.1161/strokeaha.116.012678 · Cited by 14
Poddar, R., Rajagopal, S., Winter, L., Allan, A. M., & Paul, S. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17747193 · Cited by 14
Opposing action of conantokin-G on synaptically and extrasynaptically-activated NMDA receptors
Balsara, R. D., Li, N. Y., Weber‐Adrian, D., Huang, L., & Castellino, F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.018 · Cited by 15
Shakova, F. M., Kirova, Y. I., Silachev, D. N., Romanova, G. A., & Morozov, S. G. (2021) · Brain Sciences · doi:10.3390/brainsci11030325 · Cited by 13
“The hypoxia-inducible transcription factor HIF-1α plays a primary role in the negative regulation of PGC-1α [84].”
BackgroundThe α2δ-1-NMDA receptor complex and its potential as a therapeutic target for ischemic stroke
Wu, T., Chen, S., Pan, H., & Luo, Y. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1148697 · Cited by 13
Sui, A., Piao, H. Z., Xiong, S.-T., Zhang, P., Guo, S., Kong, Y., Gao, C., Wang, Z., Yang, J., Ge, B.-Y., et al. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176704 · Cited by 13
Li, Y., Zhang, Y., Song, Q., Liu, F., Liu, Y., Li, Y., Zhou, C., & Shen, J. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04291-5 · Cited by 13
Self-citationBekhbat, M., Block, A. M., Dickinson, S. Y., Tharpd, G. K., Bosinger, S. E., & Felger, J. C. (2025) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2025.01.010 · Cited by 13
Jung, Y. J., Suh, E. C., & Lee, K. E. (2012) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2012.16.6.423 · Cited by 12
Wang, S., Wang, S., Wang, Y., Yu, X., Zhang, J., Yang, Z. R., & Liu, C. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135750 · Cited by 13
Self-citationLyons, C. E., Zhou, X., Razzoli, M., Chen, M., Xia, W., Ashe, K. H., Zhang, B., & Bartolomucci, A. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15329 · Cited by 14
Yang, J., Hu, D., Xia, J., Liu, J., Zhang, G., Gendelman, H. E., Boukli, N. M., & Xiong, H. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9468-2 · Cited by 13
Noh, J., Lee, E., & Chung, J.-M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06044.x · Cited by 13
Ni, M., Zhang, J., Huang, L., Liu, G., & Li, Q. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.08.012 · Cited by 12
Szychowski, K. A., & Gmiński, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-56781-5 · Cited by 13
Drastichová, Z., Rudajev, V., Pallag, G., & Novotný, J. (2021) · Biological Research · doi:10.1186/s40659-021-00327-5 · Cited by 12
Zamzow, C. R., Bose, R., & Parkinson, F. E. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-075 · Cited by 13
Shah, F. A., Albaqami, F. F., Alattar, A., Alshaman, R., Zaitone, S. A., Gabr, A. M., Abdel-Moneim, A.-M. H., dosoky, M. E., & Koh, P. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28016 · Cited by 12
RetractedMonnerie, H., Hsu, F.-C., Coulter, D. A., & Roux, P. D. L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.09.050 · Cited by 12
Hanuska, A., Szénási, G., Albert, M., Köles, L., Varga, A., Szabó, A., Mátyus, P., & Hársing, L. G. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1713-z · Cited by 12
Development of NMDAR Antagonists with Reduced Neurotoxic Side Effects: a Study on GK11
Vandame, D., Ulmann, L., Teigell, M., Prieto-Cappellini, M., Vignon, J., Privat, A., Perez‐Polo, R. J., Nešić, O., & Hirbec, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081004 · Cited by 12
Voluntary exercise rescues sevoflurane-induced memory impairment in aged male mice
Tian, D., Tian, M., Ma, Z., Zhang, L., Cui, Y., & Li, J. (2016) · Experimental Brain Research · doi:10.1007/s00221-016-4756-8 · Cited by 12
Song, Z., Yang, W., Cheng, G., Zhou, X., Yang, L., & Zhao, D. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0576-z · Cited by 12
Sprouty1 regulates neuritogenesis and survival of cortical neurons
Gu, X., Su, X., Jia, C., Lin, L., Liu, S., Zhang, P., Wang, X., & Jiang, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27949 · Cited by 10
Hársing, L. G., Szénási, G., Zelles, T., & Köles, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126209 · Cited by 12
Perspective of synaptic protection after post-infarction treatment with statins
Vargas, J. A. G., Céspedes-Rubio, Á. E., & Cardona‐Gómez, G. P. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0472-6 · Cited by 12
Apland, J. P., Aroniadou‐Anderjaska, V., Figueiredo, T. H., Pidoplichko, V. I., Rossetti, K., & Braga, M. F. M. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245969 · Cited by 12
Pawlak, C. R., Chen, F., Wu, F.-Y., & Ho, Y. (2012) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/j.kjms.2012.02.010 · Cited by 11
Cellular Effects of Rhynchophylline and Relevance to Sleep Regulation
Roig, M. N. B., Leduc, T., Areal, C. C., & Mongrain, V. (2021) · Clocks & Sleep · doi:10.3390/clockssleep3020020 · Cited by 12
Chen, F., Wang, L., Jin, F., Li, L., Wang, T., Gao, M., Li, L., Wang, Y., Lou, Z., Yang, J., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416150 · Cited by 11
Self-citationExcitatory amino acids in neurological and neurodegenerative disorders.
Flores, G., Negrete-Díaz, J. V., Carrión, M., Andrade‐Talavera, Y., Bello, S. A., Sihra, T. S., & Rodríguez-Moreno, A. (2011) · CABI eBooks · doi:10.1079/9781845937980.0427 · Cited by 11
Cloning, expression, and purification of a recombinant Tat-HA-NR2B9c peptide
Zhou, H.-H., Zhang, A., Zhang, Y., & Zhu, D. (2012) · Protein Expression and Purification · doi:10.1016/j.pep.2012.08.011 · Cited by 11
Rittase, W. B., Dong, Y., Barksdale, D., Galdzicki, Z., & Bausch, S. B. (2014) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2014.04.002 · Cited by 11
Sarnico, I., Boroni, F., Benarese, M., Alghisi, M., Valerio, A., Battistin, L., Spano, P., & Pizzi, M. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-007-0016-1 · Cited by 11
The Good and Bad Sides of NAAG
Khacho, P., Wang, B., & Bergeron, R. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2016.01.003 · Cited by 10
Kontić, M. Z., Drakulić, D., Stojanović, I. G., Mitrović, N., Grković, I., & Martinović, J. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.023 · Cited by 11
Feldmann, K. G., Chowdhury, A., Becker, J. L., McAlpin, N., Ahmed, T., Haider, S., Xia, J. X. R., Diaz, K., Mehta, M., & Mano, I. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14629 · Cited by 11
Oh, S. H., Kim, H., Park, K. N., Ji, S., Park, J.-Y., Choi, S. P., Lim, J. Y., Lim, J. Y., & on behalf of CROWN Investigators (2021) · Diagnostics · doi:10.3390/diagnostics11101905 · Cited by 10
Farjam, M., Zarandi, F. B. B., Farjadian, S., Geramizadeh, B., Nikseresht, A. R., & Panjehshahin, M. R. (2014) · PubMed Central · Cited by 11
Hsp70 promotes synaptic transmission in brain slices damaged by contact with blood clot
Mokrushin, A. A., & Pavlinova, L. I. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.12.004 · Cited by 11
TRPC6 expression in neurons is differentially regulated by NR2A‐ and NR2B‐containing NMDA receptors
Qu, Z., Wang, Y., Li, X., Wu, L., & Wang, Y. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14215 · Cited by 11
Self-citationTaniura, H., Iijima, S., Kambe, Y., Georgiev, D. D., & Yoneda, Y. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.126 · Cited by 11
Behroozi, Z., Askarpour, H., & Baghcheghi, Y. (2026) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823261415807 · Cited by 10
Fan, G., Liu, J., Liu, M., & Huang, Y. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.12.029 · Cited by 10
Jara, C., Torres, A. K., Park-Kang, H. S., Sandoval, L., Retamal, C., González, A., Ricca, M., Valenzuela, S., Murphy, M. P., Inestrosa, N. C., et al. (2025) · Neurotoxicity Research · doi:10.1007/s12640-024-00726-y · Cited by 12
Future Perspectives of NMDAR in CNS Disorders
Capó, T., Rebassa, J. B., Raïch, I., Lillo, J., Badia, P., Navarro, G., & Reyes‐Resina, I. (2025) · Molecules · doi:10.3390/molecules30040877 · Cited by 12
Neuroinflammation to neurodegeneration: Boulevard of broken nerves
Attiq, A., Afzal, S., Raman, H., & Ahmad, W. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115015 · Cited by 12
Yue, Y., Gao, H., Liu, W., Jiang, X., Shen, Z., Li, X., Ren, T., Xu, Z., Cheng, G., & Zhao, Q. (2020) · Toxicology in Vitro · doi:10.1016/j.tiv.2020.104888 · Cited by 10
Gakare, S. G., Varghese, S. S., Patni, P., Wagh, S. A., & Ugale, R. R. (2021) · Behavioural Brain Research · doi:10.1016/j.bbr.2021.113557 · Cited by 10
Gori, B., & Girardi, E. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9947-2 · Cited by 10
Briz, V., Parkash, J., Sánchez‐Redondo, S., Prévot, V., & Sunol, C. E. (2011) · Endocrinology · doi:10.1210/en.2011-1333 · Cited by 10
Cheng, Q., Sun, G., Liu, S., Yang, Q., Li, X., Li, X., Liu, G., Zhao, J., & Zhao, M. (2016) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12606 · Cited by 10
Role of GluN2A NMDA receptor in homocysteine-induced prostaglandin E2 release from neurons
Rajagopal, S., Fitzgerald, A., Deep, S., Paul, S., & Poddar, R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14775 · Cited by 12
Djemil, S., Chen, X., Zhang, Z., Lee, J., Rauf, M., Pak, D. T. S., & Dzakpasu, R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14938 · Cited by 13
Liu, X., & Wang, J. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.07.017 · Cited by 10
Vesicular Glutamate Release from Feeder-FreehiPSC-Derived Neurons
Baldassari, S., Cervetto, C., Amato, S., Fruscione, F., Balagura, G., Pelassa, S., Musante, I., Iacomino, M., Traverso, M., Corradi, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810545 · Cited by 10
Zheng, C., Qiao, Z., Hou, M. Z., Liu, N. N., Fu, B., Ding, R., Li, Y. Y., Wei, L. P., Liu, A. L., & Shen, H. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00186 · Cited by 10
Li, J., Yan, D., Liu, X., Wang, Y., Zhao, X., Zhang, Y., & Zhang, C. (2018) · Neurological Research · doi:10.1080/01616412.2018.1441693 · Cited by 10
Self-citationHypoxia and interleukin-1-primed mesenchymal stem/stromal cells as novel therapy for stroke
Salaudeen, M. A., Allan, S. M., & Pinteaux, E. (2023) · Human Cell · doi:10.1007/s13577-023-00997-1 · Cited by 9
Ai, H., Lu, W., Ye, M., & Yang, W. (2013) · Neuroscience Bulletin · doi:10.1007/s12264-013-1337-8 · Cited by 9
Ruden, J. B., Dixit, M., Zepeda, J. C., Grueter, B. A., & Dugan, L. L. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.777049 · Cited by 10
Chen, X., Zhu, H., liu, X., Li, Q., & Dong, M. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117236 · Cited by 9
Reversible Control of Native GluN2B-Containing NMDA Receptors with Visible Light
Geoffroy, C., Berraud-Pache, R., Chéron, N., McCort-Tranchepain, I., Doria, J., Paoletti, P., & Mony, L. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00247 · Cited by 9
She, K., Rose, J. K., & Craig, A. M. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.08.001 · Cited by 9
Self-citationNeuroprotective strategies for NMDAR-mediated excitotoxicity in Huntington’s Disease
Girling, K., & Wang, Y. T. (2016) · Frontiers in Biology · doi:10.1007/s11515-016-1425-z · Cited by 9
Self-citationHume, A. W., & Tasker, R. A. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00138-3 · Cited by 9
Rajagopal, S., Yang, C., DeMars, K. M., Poddar, R., Candelario‐Jalil, E., & Paul, S. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.12.034 · Cited by 9
Differential Effects of Human P301L Tau Expression in Young versus Aged Mice
Hunsberger, H. C., Setti, S. E., Rudy, C. C., Weitzner, D. S., Pfitzer, J. C., McDonald, K. L., Hong, H., Bhattacharya, S., Suppiramaniam, V. D., & Reed, M. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111637 · Cited by 10
Endocytosis of AMPA receptors: Role in neurological conditions
Bencsik, N., Morales, C. O. O., Haußer, A., & Schlett, K. (2022) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2022.09.007 · Cited by 9
Hypoxic Conditioning as a Stimulus for the Formation of Hypoxic Tolerance of the Brain
Semenov, D. G., & Belyakov, A. V. (2023) · Успехи физиологических наук · doi:10.31857/s0301179823020066 · Cited by 8
The ERK signaling pathway in cerebral ischemic stroke: Mechanism and therapeutic significance
Yin, X., Chang, J., Yang, L., Jia, L.-Y., Han, J., Chen, L., Cao, J., Chen, X., Xie, N., Lin, Y., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119058 · Cited by 8
Gao, J., Wang, X., Kong, X., Yao, X., Ren, J., Chen, S., Shen, N., Li, Z., Wang, Y., Ye, W., et al. (2023) · ACS Applied Polymer Materials · doi:10.1021/acsapm.3c02034 · Cited by 8
Self-citationZHANG, X.-T. Z., Peng, K.-Z., Xu, S.-L., WU, M.-X., Sun, H.-J., ZHAO, J., Yang, S., LIU, S.-J., LIAO, C.-Y., & ZHANG, X.-M. (2023) · Physiological Research · doi:10.33549/physiolres.935044 · Cited by 8
Mottarlini, F., Targa, G., Rizzi, B., Fumagalli, F., & Caffino, L. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111065 · Cited by 8
Mesfin, M. N., von Reyn, C. R., Mott, R., Putt, M., & Meaney, D. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2253 · Cited by 8
McCool, B. A., & McGinnis, M. M. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_296 · Cited by 9
Chen, Z., Wang, X., Liao, H., Sheng, T., Chen, P., Zhou, H., Pan, Y., Liu, W., & Yao, H. (2020) · PubMed Central · Cited by 8
Chen, J., Zhuang, Y., Zhang, Y., Liao, H., Liu, R., Cheng, J., Zhang, Z., Sun, J., Gao, J., Wang, X., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.950376 · Cited by 8
Wang, X.-Y., Wang, H., Fu, X.-H., Zhang, W., Wu, X., Guo, Q., & Wang, X. (2012) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2012.01.005 · Cited by 8
Nonselective Cation Channels and Links to Hippocampal Ischemia, Aging, and Dementia
MacDonald, J. F., Belrose, J. C., Xie, Y., & Jackson, M. F. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4756-6_37 · Cited by 8
Turner, L. A., Easton, A. A., Ferguson, M. M., & Danzmann, R. G. (2025) · PLoS ONE · doi:10.1371/journal.pone.0312694 · Cited by 9
Development of GluN2A NMDA receptor positive allosteric modulators: Recent advances and perspectives
Li, P., Wang, J., Wang, M., Chen, X., Zhu, H., & Dong, M. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118194 · Cited by 7
How to Pick a Neuroprotective Drug in Stroke Without Losing Your Mind?
Tauskela, J. S., & Blondeau, N. (2025) · Life · doi:10.3390/life15060883 · Cited by 7
Khan, S. A., Khan, M. M., Badruddeen, B., Ahmad, U., Akhtar, W., & Islam, A. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04357-8 · Cited by 8
New advances in small molecule drugs targeting NMDA receptors
Zeng, Y., Qu, Z.-Y., Zhu, Q., Wang, H., Zhou, Y., & Gao, Z.-B. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01675-8 · Cited by 8
Cerebral proteome adaptations to amyloid angiopathy are prevented by carbonic anhydrase inhibitors
Carlsen, J., Fossati, S., Østergaard, L., Gutiérrez‐Jiménez, E., & Palmfeldt, J. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70122 · Cited by 7
Harris, K., Won, S. J., Uruk, G., Mai, N., Ogut, D., Zhao, Y., Xie, L., Baxter, P. S., Everaerts, K., Sah, R., et al. (2025) · Science Advances · doi:10.1126/sciadv.adw0424 · Cited by 7
Sun, T., Liu, J., Ding, J., Zhang, C., Zhang, Y.-W., Ma, Q., & Liu, Y. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.262597 · Cited by 7
Self-citationAchzet, L. M., Astruc‐Diaz, F., Beske, P. H., Natale, N. R., Denton, T. T., & Jackson, D. A. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13050636 · Cited by 7
Dou, Y., Wu, X., Fei, X., & Fei, Z. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.11.020 · Cited by 7
Targeting NMDA receptor signaling for therapeutic intervention in brain disorders
Chen, H., Dong, Y., Wu, Y. J., & Yi, F. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0096 · Cited by 7
Montori, S., Dos-Anjos, S., Poole, A. V., Regueiro-Purriños, M. M., Llorente, I. L., Darlison, M. G., Fernández‐López, A., & Martínez‐Villayandre, B. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01254.x · Cited by 7
Glycine regulates proliferation and differentiation of salivary-gland-derived progenitor cells
Nakamura, Y., Matsumoto, S., Mochida, T., Nakamura, K., Takehana, K., & Endo, F. (2009) · Cell and Tissue Research · doi:10.1007/s00441-009-0767-0 · Cited by 7
Band, M., Malik, A., Joel, A., & Avivi, A. (2012) · Journal of Comparative Physiology B · doi:10.1007/s00360-012-0669-4 · Cited by 7
Kikuchi, T., Fukuta, T., Agato, Y., Yanagida, Y., Ishii, T., Koide, H., Shimizu, K., Oku, N., & Asai, T. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.09.006 · Cited by 7
The international ENIGMA-II substudy on postoperative cognitive disorders (ISEP)
Haller, G., Chan, M. T. V., Combescure, C., Lopez, U., Pichon, I., Licker, M. J., Fournier, R., & Myles, P. S. (2021) · Scientific Reports · doi:10.1038/s41598-021-91014-8 · Cited by 7
Alva-Sánchez, C., Rodríguez-Rodríguez, A., Villanueva, I., Anguiano, B., Aceves, C., & Pacheco-Rosado, J. (2014) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2014-1978 · Cited by 7
Caffino, L., Targa, G., Mallien, A. S., Mottarlini, F., Rizzi, B., Homberg, J. R., Gass, P., & Fumagalli, F. (2023) · Current Neuropharmacology · doi:10.2174/1570159x21666230913144420 · Cited by 6
Metadata
- Authors
- Liu, Y., Wong, T. P., Aarts, M., Rooyakkers, A., Liu, L., Lai, T. W., Wu, D. C., Lu, J., Tymianski, M., Craig, A. M., & Wang, Y. T.
- Affiliations
- University of British Columbia (CA)
- Toronto Western Hospital (CA)
- University of British Columbia Hospital (CA)
- Corresponding author
- Wang, Yu Tian
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-03-14
- Volume
- 27
- Issue
- 11
- Pages
- 2846-2857
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6672582
- OpenAlex
- W2097095684
- Cited by
- 773
- References
- 77
- Citations by year
- 2026: 10 · 2025: 25 · 2024: 22 · 2023: 30 · 2022: 23 · 2021: 51 · 2020: 43 · 2019: 35 · 2018: 44 · 2017: 39 · 2016: 50 · 2015: 39 · 2014: 58 · 2013: 48 · 2012: 72
- FWCI
- 18.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart and Stroke Foundation of Canada
- Heart and Stroke Foundation of British Columbia and Yukon
- Canadian Stroke Network
- Michael Smith Health Research BC
- Novartis Pharma
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Keywords
- NMDA receptor subunits, NR2A, NR2B, excitotoxicity, ischemic stroke, neuronal apoptosis, neuroprotection, glycine, extrasynaptic NMDA receptors, synaptic NMDA receptors, infarct size, cortical cultures, focal cerebral ischemia, NMDA receptor antagonists
- MeSH terms
- Animals, Cells, Cultured, Brain Ischemia, Male, Mice, Transgenic, Neurons, Receptors, N-Methyl-D-Aspartate, Cell Death, Rats, Sprague-Dawley, Excitatory Amino Acid Agonists, Excitatory Amino Acid Antagonists, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review